Review



rabbit polyclonal igg against egfr  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Santa Cruz Biotechnology rabbit polyclonal igg against egfr
    Figure 1. Immunohistochemical analysis of <t>EGFR</t> protein expression in GC. (A) GC exhibiting weak EGFR expression. (B) GC exhibiting EGFR overexpres sion (magnification, x200). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.
    Rabbit Polyclonal Igg Against Egfr, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 566 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal igg against egfr/product/Santa Cruz Biotechnology
    Average 94 stars, based on 566 article reviews
    rabbit polyclonal igg against egfr - by Bioz Stars, 2026-03
    94/100 stars

    Images

    1) Product Images from "Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients."

    Article Title: Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients.

    Journal: Oncology letters

    doi: 10.3892/ol.2015.3875

    Figure 1. Immunohistochemical analysis of EGFR protein expression in GC. (A) GC exhibiting weak EGFR expression. (B) GC exhibiting EGFR overexpres sion (magnification, x200). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.
    Figure Legend Snippet: Figure 1. Immunohistochemical analysis of EGFR protein expression in GC. (A) GC exhibiting weak EGFR expression. (B) GC exhibiting EGFR overexpres sion (magnification, x200). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.

    Techniques Used: Immunohistochemical staining, Expressing

    Figure 2. Fluorescence in situ hybridization analysis of EGFR gene copy number in GC. EGFR produced a red signal and chromosome 7 centromere produced a green signal; nuclei were stained by DAPI which appeared as a blue signal. (A) GC cells exhibiting gene amplification demonstrated a formation of clusters with numerous signals for EGFR. (B) GC cells exhibiting increased EGFR copy number due to chromosome 7 polysomy (magnification, x100). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.
    Figure Legend Snippet: Figure 2. Fluorescence in situ hybridization analysis of EGFR gene copy number in GC. EGFR produced a red signal and chromosome 7 centromere produced a green signal; nuclei were stained by DAPI which appeared as a blue signal. (A) GC cells exhibiting gene amplification demonstrated a formation of clusters with numerous signals for EGFR. (B) GC cells exhibiting increased EGFR copy number due to chromosome 7 polysomy (magnification, x100). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.

    Techniques Used: Fluorescence, In Situ Hybridization, Produced, Staining, Amplification

    Figure 3. Survival curves constructed using the Kaplan‑Meier method and log‑rank test. (A) Survival curves revealed that GC patients exhibiting weak EGFR expression (1+) and EGFR overexpression (2+) possessed an unfavorable prognosis compared with EGFR‑negative GC patients (0). (B) Survival curves revealed that GC patients demonstrating increased EGFR gene copy numbers, as detected by FISH, possessed an unfavorable prognosis. GC, gastric carcinoma; EGFR, epidermal growth factor receptor; FISH, fluorescence in situ hybridization; Cum, cumulative.
    Figure Legend Snippet: Figure 3. Survival curves constructed using the Kaplan‑Meier method and log‑rank test. (A) Survival curves revealed that GC patients exhibiting weak EGFR expression (1+) and EGFR overexpression (2+) possessed an unfavorable prognosis compared with EGFR‑negative GC patients (0). (B) Survival curves revealed that GC patients demonstrating increased EGFR gene copy numbers, as detected by FISH, possessed an unfavorable prognosis. GC, gastric carcinoma; EGFR, epidermal growth factor receptor; FISH, fluorescence in situ hybridization; Cum, cumulative.

    Techniques Used: Construct, Expressing, Over Expression, Fluorescence, In Situ Hybridization



    Similar Products

    94
    Santa Cruz Biotechnology rabbit polyclonal igg against egfr
    Figure 1. Immunohistochemical analysis of <t>EGFR</t> protein expression in GC. (A) GC exhibiting weak EGFR expression. (B) GC exhibiting EGFR overexpres sion (magnification, x200). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.
    Rabbit Polyclonal Igg Against Egfr, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal igg against egfr/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal igg against egfr - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology rabbit polyclonal antibody against total egfr
    Deguelin reduced the expression of phosphorylated IGF1R, p-Akt, and p-ERK and induced apoptosis in SCC-4 cell lines. Subconfluent culture was treated with deguelin at different concentrations for 24 h. Whole-cell extracts were prepared and analyzed by Western blot using antibodies against p-Akt, Akt, p-ERK, and ERK (a); <t>p-EGFR,</t> EGFR, p-IGF1R, and IGF1R (b); and PARP (c-PARP, cleaved PARP; u-PARP, uncleaved PARP; total PARP, sum of cleaved and uncleaved PARP) (c). Total cell extracts from Jurkat cells: serum starved overnight and then treated with Calyculin A was used as positive control (PC) for p-Akt and Akt.
    Rabbit Polyclonal Antibody Against Total Egfr, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against total egfr/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal antibody against total egfr - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit polyclonal igg antibodies against egfr, β-pdgfr, and c-kit
    Deguelin reduced the expression of phosphorylated IGF1R, p-Akt, and p-ERK and induced apoptosis in SCC-4 cell lines. Subconfluent culture was treated with deguelin at different concentrations for 24 h. Whole-cell extracts were prepared and analyzed by Western blot using antibodies against p-Akt, Akt, p-ERK, and ERK (a); <t>p-EGFR,</t> EGFR, p-IGF1R, and IGF1R (b); and PARP (c-PARP, cleaved PARP; u-PARP, uncleaved PARP; total PARP, sum of cleaved and uncleaved PARP) (c). Total cell extracts from Jurkat cells: serum starved overnight and then treated with Calyculin A was used as positive control (PC) for p-Akt and Akt.
    Rabbit Polyclonal Igg Antibodies Against Egfr, β Pdgfr, And C Kit, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal igg antibodies against egfr, β-pdgfr, and c-kit/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal igg antibodies against egfr, β-pdgfr, and c-kit - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 1. Immunohistochemical analysis of EGFR protein expression in GC. (A) GC exhibiting weak EGFR expression. (B) GC exhibiting EGFR overexpres sion (magnification, x200). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.

    Journal: Oncology letters

    Article Title: Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients.

    doi: 10.3892/ol.2015.3875

    Figure Lengend Snippet: Figure 1. Immunohistochemical analysis of EGFR protein expression in GC. (A) GC exhibiting weak EGFR expression. (B) GC exhibiting EGFR overexpres sion (magnification, x200). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.

    Article Snippet: Immunohistochemical staining of samples was performed using rabbit polyclonal IgG against EGFR (anti‐EGFR; 1:50; sc03; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) and avidin-biotin-peroxidase techniques (VECTASTAIN® Elite ABC kit; Vector Laboratories, Inc., Burlingame, CA, USA).

    Techniques: Immunohistochemical staining, Expressing

    Figure 2. Fluorescence in situ hybridization analysis of EGFR gene copy number in GC. EGFR produced a red signal and chromosome 7 centromere produced a green signal; nuclei were stained by DAPI which appeared as a blue signal. (A) GC cells exhibiting gene amplification demonstrated a formation of clusters with numerous signals for EGFR. (B) GC cells exhibiting increased EGFR copy number due to chromosome 7 polysomy (magnification, x100). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.

    Journal: Oncology letters

    Article Title: Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients.

    doi: 10.3892/ol.2015.3875

    Figure Lengend Snippet: Figure 2. Fluorescence in situ hybridization analysis of EGFR gene copy number in GC. EGFR produced a red signal and chromosome 7 centromere produced a green signal; nuclei were stained by DAPI which appeared as a blue signal. (A) GC cells exhibiting gene amplification demonstrated a formation of clusters with numerous signals for EGFR. (B) GC cells exhibiting increased EGFR copy number due to chromosome 7 polysomy (magnification, x100). EGFR, epidermal growth factor receptor; GC, gastric carcinoma.

    Article Snippet: Immunohistochemical staining of samples was performed using rabbit polyclonal IgG against EGFR (anti‐EGFR; 1:50; sc03; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) and avidin-biotin-peroxidase techniques (VECTASTAIN® Elite ABC kit; Vector Laboratories, Inc., Burlingame, CA, USA).

    Techniques: Fluorescence, In Situ Hybridization, Produced, Staining, Amplification

    Figure 3. Survival curves constructed using the Kaplan‑Meier method and log‑rank test. (A) Survival curves revealed that GC patients exhibiting weak EGFR expression (1+) and EGFR overexpression (2+) possessed an unfavorable prognosis compared with EGFR‑negative GC patients (0). (B) Survival curves revealed that GC patients demonstrating increased EGFR gene copy numbers, as detected by FISH, possessed an unfavorable prognosis. GC, gastric carcinoma; EGFR, epidermal growth factor receptor; FISH, fluorescence in situ hybridization; Cum, cumulative.

    Journal: Oncology letters

    Article Title: Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients.

    doi: 10.3892/ol.2015.3875

    Figure Lengend Snippet: Figure 3. Survival curves constructed using the Kaplan‑Meier method and log‑rank test. (A) Survival curves revealed that GC patients exhibiting weak EGFR expression (1+) and EGFR overexpression (2+) possessed an unfavorable prognosis compared with EGFR‑negative GC patients (0). (B) Survival curves revealed that GC patients demonstrating increased EGFR gene copy numbers, as detected by FISH, possessed an unfavorable prognosis. GC, gastric carcinoma; EGFR, epidermal growth factor receptor; FISH, fluorescence in situ hybridization; Cum, cumulative.

    Article Snippet: Immunohistochemical staining of samples was performed using rabbit polyclonal IgG against EGFR (anti‐EGFR; 1:50; sc03; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) and avidin-biotin-peroxidase techniques (VECTASTAIN® Elite ABC kit; Vector Laboratories, Inc., Burlingame, CA, USA).

    Techniques: Construct, Expressing, Over Expression, Fluorescence, In Situ Hybridization

    Deguelin reduced the expression of phosphorylated IGF1R, p-Akt, and p-ERK and induced apoptosis in SCC-4 cell lines. Subconfluent culture was treated with deguelin at different concentrations for 24 h. Whole-cell extracts were prepared and analyzed by Western blot using antibodies against p-Akt, Akt, p-ERK, and ERK (a); p-EGFR, EGFR, p-IGF1R, and IGF1R (b); and PARP (c-PARP, cleaved PARP; u-PARP, uncleaved PARP; total PARP, sum of cleaved and uncleaved PARP) (c). Total cell extracts from Jurkat cells: serum starved overnight and then treated with Calyculin A was used as positive control (PC) for p-Akt and Akt.

    Journal: BioMed Research International

    Article Title: Deguelin Induces Apoptosis by Targeting Both EGFR-Akt and IGF1R-Akt Pathways in Head and Neck Squamous Cell Cancer Cell Lines

    doi: 10.1155/2015/657179

    Figure Lengend Snippet: Deguelin reduced the expression of phosphorylated IGF1R, p-Akt, and p-ERK and induced apoptosis in SCC-4 cell lines. Subconfluent culture was treated with deguelin at different concentrations for 24 h. Whole-cell extracts were prepared and analyzed by Western blot using antibodies against p-Akt, Akt, p-ERK, and ERK (a); p-EGFR, EGFR, p-IGF1R, and IGF1R (b); and PARP (c-PARP, cleaved PARP; u-PARP, uncleaved PARP; total PARP, sum of cleaved and uncleaved PARP) (c). Total cell extracts from Jurkat cells: serum starved overnight and then treated with Calyculin A was used as positive control (PC) for p-Akt and Akt.

    Article Snippet: Mouse monoclonal antibody against phosphorylated-ERK1/2 (p-ERK1/2) and rabbit polyclonal antibody against total EGFR were from Santa Cruz Biotechnology (Dallas, TX, USA).

    Techniques: Expressing, Western Blot, Positive Control

    Deguelin induced apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in HNSCC cell lines. Subconfluent cultures were incubated for 24 h in serum-free medium. After the starvation, cells were treated with 10 μ M deguelin for 1 h. (a) The deguelin-treated SCC-4 cells were incubated for 15 min and 24 h with or without 10 ng/ml of IGF, respectively. (b) The deguelin-treated HSC-4 cells were incubated for 24 h with or without 10 ng/ml of EGF. Whole-cell extracts were analyzed by Western blot using antibodies against p-Akt, Akt, and PARP. (c) HSC-4 cells were treated with deguelin at different concentrations for 24 h in 10% FBS-containing medium. Whole-cell extracts were analyzed by Western blot using antibodies against p-EGFR, EGFR, and PARP (c-PARP, cleaved PARP; u-PARP, uncleaved PARP; total PARP, sum of cleaved and uncleaved PARP).

    Journal: BioMed Research International

    Article Title: Deguelin Induces Apoptosis by Targeting Both EGFR-Akt and IGF1R-Akt Pathways in Head and Neck Squamous Cell Cancer Cell Lines

    doi: 10.1155/2015/657179

    Figure Lengend Snippet: Deguelin induced apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in HNSCC cell lines. Subconfluent cultures were incubated for 24 h in serum-free medium. After the starvation, cells were treated with 10 μ M deguelin for 1 h. (a) The deguelin-treated SCC-4 cells were incubated for 15 min and 24 h with or without 10 ng/ml of IGF, respectively. (b) The deguelin-treated HSC-4 cells were incubated for 24 h with or without 10 ng/ml of EGF. Whole-cell extracts were analyzed by Western blot using antibodies against p-Akt, Akt, and PARP. (c) HSC-4 cells were treated with deguelin at different concentrations for 24 h in 10% FBS-containing medium. Whole-cell extracts were analyzed by Western blot using antibodies against p-EGFR, EGFR, and PARP (c-PARP, cleaved PARP; u-PARP, uncleaved PARP; total PARP, sum of cleaved and uncleaved PARP).

    Article Snippet: Mouse monoclonal antibody against phosphorylated-ERK1/2 (p-ERK1/2) and rabbit polyclonal antibody against total EGFR were from Santa Cruz Biotechnology (Dallas, TX, USA).

    Techniques: Incubation, Western Blot